Roche gets go ahead for Ebola detection test
AFP · 29 Dec 2014, 17:05
Published: 29 Dec 2014 17:05 GMT+01:00
- WHO downplays Ebola vaccine trial suspension (11 Dec 14)
- Ebola worries offset malaria gains: WHO (09 Dec 14)
- WHO lowers Ebola death toll after counting 'error' (02 Dec 14)
The US Food and Drug Administration authorized the test for emergency use on patients with signs and symptoms of the deadly virus, Roche said.
"The LightMix Ebola Zaire test is an easy-to-use molecular diagnostic test providing a solution for healthcare professionals to quickly detect the virus and start patient treatment as early as possible," said Roland Diggelmann, chief operations officer of Roche's diagnostics division.
The test, manufactured by German company TIB MOLBIOL GmbH, has also been given the European CE mark indicating it conforms with EU regulations.
Mobile laboratories in the three west African nations hard hit by Ebola -- Guinea, Sierra Leone and Liberia -- currently use expensive and time-consuming tests that can take up to six hours.
Ebola has killed more than 7,500 people over the past year, almost all of them in Liberia, Guinea and Sierra Leone.